BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 92320)

  • 1. [Modifications in alpha 2 globulins, gamma globulins and in rheumatoid factor during gold salt therapy in rheumatoid arthritis].
    Gropuzzo M; Masoch G; Gambari PF; Todesco S
    Boll Soc Ital Biol Sper; 1978 Dec; 54(23):2435-9. PubMed ID: 92320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of chrysotherapy on various immunological parameters in rheumatoid polyarthritis].
    Carcassi U; Ibba G; Uras R; Perpignano G
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):273-5. PubMed ID: 6879093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous synthesis of IgM rheumatoid factor by blood mononuclear cells from patients with rheumatoid arthritis: effect of treatment with gold salts or D-penicillamine.
    Olsen N; Ziff M; Jasin HE
    J Rheumatol; 1984 Feb; 11(1):17-21. PubMed ID: 6699830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gold treatment of progressive chronic polyarthritis--a clinical study].
    Knoche U; Wagner H; Hauss WH
    Z Rheumatol; 1975; 34(5-6):203-12. PubMed ID: 779340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of D-penicillamine on serum immunoglobulins in rheumatoid arthritis].
    Gambari PF; Mioni E; Ostuni A; Volante D; Punzi L; Todesco S; Ongaro G
    Boll Soc Ital Biol Sper; 1981 May; 57(10):1127-31. PubMed ID: 6794580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of treatment outcome in patients with rheumatoid arthritis treated with TFX- Polfa or gold salts after a one year follow up].
    Lewandowicz J
    Pol Tyg Lek; 1992 Dec 7-14; 47(49-50):1102-4. PubMed ID: 1305735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of gold salts on rheumatoid factor dynamics in patients with rheumatoid arthritis].
    Vlak T; Jajić I
    Reumatizam; 1992; 39(1):11-3. PubMed ID: 1366138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pattern of rheumatoid arthritis in patients with rheumatoid nodules.
    Maldyk H; Slotwińska L
    Pol Med J; 1971; 10(1):24-30. PubMed ID: 4102356
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal tubular dysfunction as a complication of gold therapy in patients with rheumatoid arthritis.
    Iesato K; Mori Y; Ueda S; Wakashin Y; Wakashin M; Matsui N; Inoue S; Okuda K
    Clin Nephrol; 1982 Jan; 17(1):46-52. PubMed ID: 7035044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between fibronectin, rheumatoid factor and aggregated gamma globulins.
    Ferraccioli G; Karsh J; Osterland CK
    J Rheumatol; 1985 Aug; 12(4):680-4. PubMed ID: 2414445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement.
    Alessandri C; Bombardieri M; Papa N; Cinquini M; Magrini L; Tincani A; Valesini G
    Ann Rheum Dis; 2004 Oct; 63(10):1218-21. PubMed ID: 15361374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dynamics of circulating anti-tissue antibodies and titer of rheumatoid factor in rheumatoid polyarthritis under the effect of immunosuppressive drugs, antimalarials and gold salts].
    Andreev T; Kozhukharova M; Pilosof T
    Vutr Boles; 1972; 11(3):125-8. PubMed ID: 4547886
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative studies on the immunodepressive effect of D-penicillamine and gold salts in chronic progressive polyarhtritis].
    Miehlke K; Kohlhardt I; Wirth B
    Z Rheumaforsch; 1968 Dec; 27(11):445-54. PubMed ID: 5710880
    [No Abstract]   [Full Text] [Related]  

  • 14. Imipramine and rheumatoid factor.
    MacNeill AL; Dick WC
    J Int Med Res; 1976; 4(2 Suppl):23-7. PubMed ID: 799987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of high-dose pulse methylprednisolone in rheumatoid arthritis. Unproved therapy.
    Barry M
    Arch Intern Med; 1985 Aug; 145(8):1483-4. PubMed ID: 2411240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class specific rheumatoid factors in rheumatoid arthritis: response to chrysotherapy and relationship to disease activity.
    Rudge SR; Pound JD; Bossingham DH; Powell RJ
    J Rheumatol; 1985 Jun; 12(3):432-6. PubMed ID: 3930719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gold salt therapy in rheumatoid arthritis].
    Ballabio CB; Amira A; Carrabba M
    Reumatismo; 1970; 22(1):Suppl:79-95. PubMed ID: 5524873
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of gold therapy in rheumatoid arthritis on leukopoiesis and granulocyte phagocytosis].
    Nowotny P; Konrad H; Preussner S; Bast G; Keysser M; Günther I
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(5):719-25. PubMed ID: 64413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum levels of immunoglobulins G, M and A in rheumatoid arthritis].
    Claessens HI; Veys EM
    Rev Rhum Mal Osteoartic; 1968 Dec; 35(12):635-41. PubMed ID: 4180428
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral chrysotherapy in rheumatoid arthritis: minimum effective dose.
    Finkelstein AE; Roisman FR; Batista V; de Nudelman FG; de Titto EH; Mizraji M; Walz DT
    J Rheumatol; 1980; 7(2):160-8. PubMed ID: 6768887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.